Iovance Biotherapeutics, Inc. (IOVA)
8.445
+0.38
(+4.78%)
USD |
NASDAQ |
Aug 25, 16:00
8.43
-0.02
(-0.18%)
After-Hours: 19:59
Iovance Biotherapeutics 1 Year Total Returns (Daily) : 199.6% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 199.6% |
| August 21, 2026 | 226.4% |
| August 20, 2026 | 255.3% |
| August 19, 2026 | 207.3% |
| August 18, 2026 | 181.2% |
| August 17, 2026 | 178.4% |
| August 14, 2026 | 184.9% |
| August 13, 2026 | 166.1% |
| August 12, 2026 | 202.2% |
| August 11, 2026 | 229.4% |
| August 10, 2026 | 203.3% |
| August 07, 2026 | 140.2% |
| August 06, 2026 | 140.7% |
| August 05, 2026 | 57.82% |
| August 04, 2026 | 54.06% |
| August 03, 2026 | 61.01% |
| July 31, 2026 | 58.37% |
| July 30, 2026 | 75.66% |
| July 29, 2026 | 56.16% |
| July 28, 2026 | 59.32% |
| July 27, 2026 | 56.55% |
| July 24, 2026 | 51.67% |
| July 23, 2026 | 29.22% |
| July 22, 2026 | 65.18% |
| July 21, 2026 | 120.1% |
| Date | Value |
|---|---|
| July 20, 2026 | 125.1% |
| July 17, 2026 | 113.7% |
| July 16, 2026 | 109.0% |
| July 15, 2026 | 144.3% |
| July 14, 2026 | 95.52% |
| July 13, 2026 | 116.0% |
| July 10, 2026 | 119.2% |
| July 09, 2026 | 119.6% |
| July 08, 2026 | 141.8% |
| July 07, 2026 | 155.9% |
| July 06, 2026 | 139.4% |
| July 02, 2026 | 146.3% |
| July 01, 2026 | 128.2% |
| June 30, 2026 | 141.9% |
| June 29, 2026 | 149.1% |
| June 26, 2026 | 144.3% |
| June 25, 2026 | 136.5% |
| June 24, 2026 | 126.1% |
| June 23, 2026 | 140.0% |
| June 22, 2026 | 105.1% |
| June 18, 2026 | 91.67% |
| June 17, 2026 | 94.55% |
| June 16, 2026 | 83.65% |
| June 15, 2026 | 79.91% |
| June 12, 2026 | 76.62% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Agenus, Inc. | 69.69% |
| Amgen, Inc. | 55.28% |
| Neurocrine Biosciences, Inc. | 13.00% |
| Anika Therapeutics, Inc. | 121.1% |
| BioCryst Pharmaceuticals, Inc. | 13.08% |